Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodaySmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
Omaxe
Small Cap•484 Employees•IPO 2007
Current Price
₹72.37
-0.38 (-0.52%)Updated
Today's Range
72.16
₹72.37
73.91
52 Week Range
52W Low₹62.50
52W High₹113.40
₹72.37
Downside15.79%
Upside56.69%
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹1,439.43 Cr
Market Cap
Total market value of companyP/E Ratio
-
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
22.11
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹-35.61
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
-134.39%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
-61.40%
ROCE
Return on Capital Employed. >15% is goodNet Margin
-45.44%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
-%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
6.84%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
-17.40%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
-26.00%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
1.66
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹26.27
Book Value
Net asset value per shareDividend Yield
-%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
74.10%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
1 points- •Omaxe demonstrates strong promoter confidence with a significant holding of 74.14%, indicating stable leadership and a long-term commitment to the company's future direction and growth.
Weaknesses
6 points- •The company exhibits severe profitability issues, with a negative Return on Equity of -506% and Return on Capital Employed of -61.4%, indicating significant value destruction for shareholders.
- •Omaxe reported a substantial quarterly net loss of -186 crores, representing a -26% decline from the previous quarter, highlighting persistent operational challenges and financial instability.
Opportunities
2 points- •The broader 'Realty' sector, driven by urbanization and housing demand, presents potential for Omaxe to capitalize on market expansion if it can address its internal financial challenges.
- •Favorable government policies and infrastructure development in the 'Residential Commercial Projects' industry could stimulate demand, offering growth avenues for Omaxe.
Threats
3 points- •Intense competition from larger, more profitable peers like DLF and Lodha Developers, with significantly higher market caps and positive earnings, poses a substantial threat to Omaxe's market share.
- •The inherent cyclicality and sensitivity of the 'Realty' sector to economic downturns, interest rate changes, and regulatory shifts present ongoing market volatility risks for Omaxe.
Segment-wise Financial Analysis
Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
Recent Insider Transactions
| Insider Name | Transaction Date | Filing Date | Total Shares | Change | Price | Action |
|---|---|---|---|---|---|---|
Rohtas Goel | 20 Dec 2024 | 24 Dec 2024 | 19.62 L | 7.48 L | ₹10 | BUY |
Sunil Goel | 20 Dec 2024 | 24 Dec 2024 | 25.88 L | 7.48 L | ₹10 | SELL |
Sushma Goel | 19 Dec 2024 | 24 Dec 2024 | 8.79 L | 21,000 | ₹10 | BUY |
Seema Goel | 19 Dec 2024 | 24 Dec 2024 | - | 21,000 | ₹10 | SELL |
Sunil Goel HUF | 19 Dec 2024 | 24 Dec 2024 | - | 13,500 | ₹110.76 | SELL |
Sushma Goel | 19 Dec 2024 | 24 Dec 2024 | 8.58 L | 13,500 | ₹110.76 | BUY |
Rohtas Goel | 27 Jan 2025 | 30 Jan 2025 | 32.66 L | 13.04 L | ₹10 | BUY |
Sunil Goel | 27 Jan 2025 | 30 Jan 2025 | 12.84 L | 13.04 L | ₹10 | SELL |
Sunil Goel | 13 Mar 2025 | 18 Mar 2025 | - | 12.48 L | ₹10 | SELL |
Rohtas Goel | 13 Mar 2025 | 18 Mar 2025 | 45.50 L | 12.48 L | ₹10 | BUY |
Rohtas Goel | 12 Mar 2025 | 18 Mar 2025 | 33.02 L | 36,120 | ₹10 | BUY |
Sunil Goel | 12 Mar 2025 | 18 Mar 2025 | 12.48 L | 36,120 | ₹10 | SELL |
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹76.97 | +₹4.60 | +6.35% |
| R3 | ₹75.22 | +₹2.85 | +3.93% |
| R2 | ₹74.56 | +₹2.19 | +3.03% |
| R1 | ₹73.47 | +₹1.10 | +1.52% |
| PIVOT | ₹72.81 | 0.44 | 0.61% |
| CURRENT | ₹72.37 | - | - |
| S1 | ₹68.22 | -₹4.15 | -5.74% |
| S2 | ₹69.97 | -₹2.40 | -3.32% |
| S3 | ₹71.06 | -₹1.31 | -1.81% |
| S4 | ₹71.72 | -₹0.65 | -0.90% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume+76.5% vs avg
1.98L
(12 Mar 2026)Delivery %+21.5% vs avg
70.4%
(12 Mar 2026)Avg Volume (20D)20-day average
1.12L
(12 Feb - 12 Mar)Avg Delivery %Trend ↑
48.9%
(12 Feb - 12 Mar)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Lodha Developers Ltd
1.10L ₹ Cr
Best Profit Growth
Hubtown Ltd
1349.00 %
Highest Dividend Yield
Arvind SmartSpaces Ltd
1.08 %
Peer Comparison
| Company Name |
|---|
 AGI Infra Ltd |
 Arihant Superstructures Ltd |
 Arkade Developers Ltd |
 Arvind SmartSpaces Ltd |
 Ashiana Housing Ltd |
 Hubtown Ltd |
 Laxmi Goldorna House Ltd |
 Lodha Developers Ltd |
 Oswal Agro Mills Ltd |
 Peninsula Land Ltd |
 Raymond Realty Ltd |
 Shriram Properties Ltd |
 Suraj Estate Developers Ltd |
 Unitech Ltd |
About
Omaxe Ltd
OMAXE Limited is a prominent real estate development company operating within India. Their business model centers on creating and developing diverse real estate properties, catering to a broad spectrum of needs and market segments.
The company's portfolio is expansive and multifaceted, encompassing several key areas of real estate development. This includes residential projects, offering homes to individuals and families; commercial properties such as office spaces, designed to meet the demands of businesses of varying sizes; and retail spaces, including shopping malls, intended to attract consumers and provide retail opportunities.
Beyond these core areas, OMAXE also undertakes the development of large-scale integrated townships and hi-tech townships. These projects often involve the creation of self-contained communities offering a mix of residential, commercial, and recreational amenities. Furthermore, they participate in Public-Private Partnership (PPP) projects, collaborating with government entities to develop public infrastructure.
Other key areas of their development include the construction of SCOs (Shops, Commercial Offices), which are mixed-use properties combining retail and office spaces, and hospitality properties, such as hotels or resorts. Their portfolio even extends to developing public infrastructure and sports-related destinations, showcasing their diverse approach to real estate development.
Founded in 1987 and initially known as Omaxe Construction Limited, the company rebranded as Omaxe Limited in 2006. Currently based in New Delhi, India, OMAXE Limited is a subsidiary of Guild Builders Private Limited. Their long history and wide-ranging portfolio demonstrate a significant presence in the Indian real estate market.
COMPANY FACTS - OMAXE
Registered Address
Omaxe House, 7, LSC, Kalkaji
New Delhi
DELHI
IN
Company Details
Group: Real Estate Management & Development
Sector: Real Estate
Industry: Real Estate Management & Development
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 484
IPO Date: 11/08/2007
MANAGEMENT - OMAXE
Mr. Atul Banshal
Director - Finance
Mr. Rohtas Goel
Whole-Time Chairman of the Board
Mr. Manoj Dua
Chief Financial Officer
Mr. Deshabandhu Srikanta
Compliance Officer, Company Secretary
Mr. Mohit Goel
Managing Director, Whole Time Director
Mr. Vinit Goyal
Whole Time Director
Mr. Aroon Aggarwal
Additional Non-Executive Independent Director
Ms. Binitha Dalal
Additional Non-Executive Independent Director
Ms. Nishal Jain
Non-Executive Woman Independent Director
Mr. Shridhar Rao
Non-Executive Independent Director
Investor Questions Answered
Omaxe Ltd (OMAXE) Stock FAQs
Get answers to the most common questions about Omaxe Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of Omaxe Ltd (OMAXE) is ₹72.37. Today, the stock has declined by ₹0.38 (0.52%), trading in a range of ₹72.16 to ₹73.91. The stock opened at ₹73 with a trading volume of 28,716 shares.
Omaxe Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,439.43 crores, P/E ratio of 0.00, ROE of -134.39%, and ROCE of -61.40%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Omaxe Ltd (OMAXE) is ₹113.4, while the 52-week low is ₹62.5. Currently trading at ₹72.37, the stock is 19.4% away from its 52-week low and 36.2% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Omaxe Ltd stock at ₹72.37 depends on multiple factors. The stock is currently trading with a P/E ratio of 0.00 and P/B ratio of N/A. Today's performance shows a loss of 0.52%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Omaxe Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹72.37, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Omaxe Ltd's key financial metrics include: P/E Ratio: 0.00, P/B Ratio: N/A, ROE: -134.39%, ROCE: -61.40%, Dividend Yield: 0.00%, EPS: ₹-35.61, Book Value: ₹26.27, Debt-to-Equity: 1.66, and Current Ratio: N/A. The company's market cap stands at ₹1,439.43 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Omaxe Ltd stock opened at ₹73 and is currently trading at ₹72.37, showing a decline of ₹0.38 (0.52%). The intraday high is ₹73.91 and low is ₹72.16. The trading volume stands at 28,716 shares, indicating moderate market participation today.
Omaxe Ltd has a Price-to-Earnings (P/E) ratio of 0.00, which means investors are willing to pay ₹0.00 for every ₹1 of earnings. With an EPS of ₹-35.61, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
Omaxe Ltd has a market capitalization of ₹1,439.43 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹72.37) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Omaxe Ltd has a book value of ₹26.27 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹72.37, which is 175.5% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Omaxe Ltd has a Return on Equity (ROE) of -134.39% and Return on Capital Employed (ROCE) of -61.40%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Omaxe Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Omaxe Ltd has a debt-to-equity ratio of 1.66, which measures the company's financial leverage by comparing total debt to shareholders' equity. A ratio above 1 suggests the company uses more debt than equity for financing. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Omaxe Ltd has an Earnings Per Share (EPS) of ₹-35.61, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹72.37 and P/E ratio of 0.00, investors are paying 0.00 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Omaxe Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Omaxe Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Omaxe Ltd stock, consider: 1) Fundamental Analysis - Review P/E (0.00), ROE (-134.39%), debt-to-equity (1.66), and growth rates. 2) Technical Analysis - Check 52-week range (₹62.50 - ₹113.40), moving averages, and chart patterns. 3) Valuation - Compare current price (₹72.37) with book value (₹26.27) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Omaxe Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹72.37 is 624x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Omaxe Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹62.50 - ₹113.40). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 1.66 indicates leverage. 4) Liquidity Risk - Based on trading volume of 28,716 shares. 5) Valuation Risk - P/E of 0.00 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Omaxe Ltd operates in the industry with key metrics: P/E ratio of 0.00, ROE of -134.39%, market cap of ₹1,439.43 crores, and dividend yield of 0.00%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 1.66), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Omaxe Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹72.37, with a 52-week range of ₹62.50 to ₹113.40. Based on fundamentals like P/E (0.00), ROE (-134.39%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Omaxe Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹72.37. 2) Fundamental Deterioration - Declining ROE (currently -134.39%), increasing debt (D/E: 1.66), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Omaxe Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.00%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu